SMSbiotech is pleased to announce the successful completion of the HRIPT clinical test for its wound regeneration product, which is designated for chronic, non-healing wounds.
This clinical test was conducted by Eurofins Scientific on 50 volunteers. The second clinical test will be conducted shortly.